My PCR
Create Account
Logo PCR

21 Nov 2021

Tricuspid / Pulmonary valveMitral valve replacement and repair

PCR London Valves 2021 Hotlines / Late-Breaking Trials: bRIGHT, EXPAND, CHOICE-MI

Session comprising selected 2021 PCR London Valves Late-Breaking Trial submissions

Presenters: A. Duncan, M. Keßler, P. Lurz

Summary

Real-world outcomes for tricuspid edge-to-edge repair, predictors of heart failure hospitalisation and its impact on clinical outcomes, one-year outcomes after TMVI... View part of the Late-Breaking Trials presented during PCR London Valves 2021.

Learning Objectives

  • View the following Late-Breaking Trials presented during PCR London Valves 2021:
  • - Real-world outcomes for tricuspid edge-to-edge repair: initial 30-day results from the TriClip bRIGHT study
  • - Predictors of heart failure hospitalisation and its impact on clinical outcomes, results from the contemporary MitraClip EXPAND study
  • - One-year outcomes after transcatheter mitral valve implantation: results from the CHOICE-MI registry
Related Content
CLEAR-IE: outcomes of percutaneous mechanical aspiration in right-sided infective endocarditis Most impactful trials in structural heart disease 2024/2025 Second valves strategies with SAPIEN 3 Ultra RESILIA - Regional insights
Recommended for you
Register at Regular fee Key updates in valvular heart disease management: insights from the 2025 ESC/EACTS Guidelines AICT-AsiaPCR: what's in store this year?